Wedbush Research Analysts Reduce Earnings Estimates for ITOS
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Analysts at Wedbush reduced their Q2 2025 earnings per share (EPS) estimates for iTeos Therapeutics in a research report issued to clients and investors on Wednesday, May 28th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of ($1.48) per share for the quarter, […]
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Analysts at Wedbush reduced their Q2 2025 earnings per share (EPS) estimates for iTeos Therapeutics in a research report issued to clients and investors on Wednesday, May 28th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of ($1.48) per share for the quarter, […]
